Abstract
AimsWe examined the impact of off-label and unlicensed (OLUL) prescribing on adverse drug reaction (ADR) risk in paediatric inpatients. We hypothesised that OLUL prescribing may be a risk factor for...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have